IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


With hemp legal, firms should be careful how CBD is labeled, warns legal expert

This article is powered by Food Chemical News

While it may be a “bridge too far” for FDA to approve of cannabidiol, or CBD, in food and supplements in the near term, the 2018 Farm Bill has eased restrictions on hemp products. But companies should make sure they follow labeling and supplier guardrails so they are not targeted by regulators, said Jason Sapsin, counsel at Faegre Bakes Daniel LLP.


Related Content

FDA unveils dietary supplements overhaul, may consider reopening DSHEA
Oregon senators call on FDA to update regulations on hemp-derived foods
Experts debate path forward for FDA to regulate cannabis-infused foods


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts